Third-party disease pages (diabetes, thyroid, PCOS, kidneys, arthritis): Tayebat principles may help these conditions as an educational, supportive approach under medical supervision; they do not replace treatment.
Original statement
لا تطبّق الطيبات كاملاً دون طبيب كلى.
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Third-party disease pages (diabetes, thyroid, PCOS, kidneys, arthritis): Tayebat principles may help these conditions as an educational, supportive approach under medical supervision; they do not replace treatment.
Origin
- Source status
- Third-party site (unofficial)
- Attribution
- Third-party site (unofficial)
- Origin
- https://mytayibat.com/mytayibat-kidneys
- Attribution uncertainty
- Disease pages fetched 2026-10-25 (diabetes, thyroid, PCOS, kidneys, arthritis); not Elawady's words. mytayibat.com is an unofficial third-party site in the sense that it is neither the eltayebat.com archive nor Elawady's own words. Its footer describes it as 'المنصة الرسمية التعليمية لنظام الطيبات' ('the official educational platform of the Tayebat system'), and its pages refer to it as 'the official platform'. This self-description could not be verified: no evidence was found that the site is authorised by Dr. Diaa Elawady's heirs or by the eltayebat.com archive. By contrast, altayybat.com states that it is not affiliated with Dr. Diaa Elawady. Lowest attribution level; page fetched 2026-10-25.
- Population concerned
People with chronic conditions
- Geographic restriction by Elawady
none found
Diverging source versions
لا تغيّر جرعات الأدوية أو الأنسولين دون طبيبك.
- Source status
- Third-party site (unofficial)
- Attribution
- Third-party site (unofficial)
- Origin
- https://mytayibat.com/mytayibat-diabetes
اضطراب الغدة يؤثر على الدواء والصيام والحمل.
- Source status
- Third-party site (unofficial)
- Attribution
- Third-party site (unofficial)
- Origin
- https://mytayibat.com/mytayibat-thyroid
PCOS يتداخل مع الخصوبة والدورة والوزن والسكري.
- Source status
- Third-party site (unofficial)
- Attribution
- Third-party site (unofficial)
- Origin
- https://mytayibat.com/mytayibat-pcos
ليس بديلاً عن الأدوية والعلاج الطبيعي.
- Source status
- Third-party site (unofficial)
- Attribution
- Third-party site (unofficial)
- Origin
- https://mytayibat.com/mytayibat-arthritis
Scientific assessment
Unclear / insufficient evidence – The data do not allow an assessment either way.
Certainty of evidence: very low – Any assessment is very uncertain.
1. What was claimed?
Tayebat may support management of diabetes, thyroid disease, PCOS, kidney disease and arthritis when coordinated with physicians.
2. What is demonstrably correct?
The pages do NOT claim cures. They advise not changing insulin or drug doses without a doctor (diabetes), coordinating with endocrinologists (thyroid, PCOS), not applying the full system without a nephrologist (kidneys), and not stopping medicines (arthritis). Reducing processed food and soft drinks is reasonable general advice.
3. What is wrong or exaggerated?
Mechanistic statements attributed to Elawady on these pages (e.g., 'reducing heavy food lowers silent inflammation') are not supported by cited evidence; the arthritis page forbids legumes, refined bread and liquid dairy without evidence for joint outcomes.
4. What remains unclear?
Effect of the system on any of these conditions.
5. Which studies support it?
Partly: the ADA Standards of Care 2026 recommend individualised medical nutrition therapy, minimising sugar-sweetened beverages, refined grains, processed and ultra-processed foods, and medical oversight with possible adjustment of insulin and other medicines when diets change (I-INTC-03). This matches the pages' advice to coordinate with physicians.
6. Which studies contradict it?
The same guideline recommends eating patterns that include nonstarchy vegetables, whole fruits, legumes, whole grains and low-fat dairy (I-INTC-03), several of which the Tayebat lists exclude. No trial of the Tayebat system for diabetes, thyroid disease, PCOS, kidney disease or arthritis was found.
7. What applies to Germany and Europe?
European diabetes care also individualises nutrition therapy (EASD/ADA consensus, not audited here). No European guideline recommends the Tayebat system.
8. What is known about Egypt?
The pages are written for Arabic-speaking, largely Egyptian readers; no Egyptian data on outcomes of the system were found.
9. What practical conclusion is appropriate?
Any dietary change for these conditions should be coordinated with the treating physician, as the pages themselves say.
Assessment details
- Rationale for certainty of evidence
No trial of the Tayebat system for any of these conditions was found. The cautious advice on the pages (medical supervision, no change of medicines without a doctor) is consistent with the ADA Standards of Care 2026 (I-INTC-03), but the food exclusions partly conflict with guideline-recommended eating patterns.
- Source quality
Third-party site.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Insufficiently studied – There is too little research to say whether the claim is right or wrong.
Research question: Does following Tayebat principles as a supportive approach under medical supervision improve outcomes in diabetes, thyroid disease, PCOS, kidney disease or arthritis?
Research question in detail (PICO)
- Population
- People with these chronic conditions
- Intervention or exposure
- Tayebat principles under supervision
- Comparison
- Usual care / guideline diets
- Geographic scope
- Arabic-speaking audience; universal biology
- Outcomes
- Disease control
- Safety
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
No high-quality evidence supporting the claim was found.
What speaks against the claim?
US diabetes guideline on food and lifestyle
American Diabetes Association Professional Practice Committee. Diabetes Care 2026 · PMID 41358898 · DOI 10.2337/dc26-S005 Guideline / position statementfull text checkedADA Standards 2026 recommend patterns including legumes, vegetables, whole grains, low-fat dairy.
- Actual result
- As recorded
- Methodological quality
- high (guideline)
- Relevance
- indirect: conflicts with parts of Tayebat lists
- Limitations
- Guideline.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
No trial of the system exists for these conditions; the pages' advice to keep medical supervision is appropriate.
Why some studies weigh more
No new relevant evidence beyond the linked studies; searches for Tayebat/Elawady and Egyptian dietary RCTs found nothing specific.
Is a causal relationship established? Not established No studies.
Remaining uncertainty
Effect of the system.
Justified conclusion
Unknown.
Does this depend on the country?
- General biological effects
- Universal human biology; applies in Egypt, Germany and elsewhere.
- Eating habits
- Not decisive for this claim.
- Origin of the food
- Not relevant.
- Contaminants
- Not relevant.
- National production conditions
- Not relevant.
- Legal rules
- Not relevant.
- Actual monitoring data
- Not applicable.
A regional difference that changes the conclusion is not supported by robust data.
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Disease outcomes with Tayebat principles
- Starting level
- low (observational studies)
- Reasons for downgrading
- indirectness
- no studies
- Result
- very low
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- ADA: Standards of Care in Diabetes 2026, section 5 (I-INTC-03) (2026) · Original publication
Individualised medical nutrition therapy; eating patterns with nonstarchy vegetables, whole fruits, legumes, whole grains; medical oversight of medication when diets change (as recorded for I-INTC-03).
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| Europe PMC | 26 October 2026 | (Tayebat OR Tayibat OR Elawady OR "El-Awady diet" OR "Al-Awady") | both directions | 377 | |
| Europe PMC | 26 October 2026 | ("dietary intervention" OR "diet") AND (Egypt OR Egyptian) AND ("polycystic ovary" OR hypothyroidism OR "rheumatoid arthritis" OR "chronic kidney disease" OR "type 2 diabetes") AND (randomized OR randomised) | both directions | 3233 | |
| PubMed | 26 October 2026 | (Tayebat[tiab] OR Tayibat[tiab] OR Elawady[tiab] OR Awady[tiab]) | both directions | 10 |
How deeply was this checked?
1 linked studies: 1 checked in full text (0 of them with a structured risk-of-bias assessment), 0 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: Unclear / insufficient evidence (very low)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Unclear / insufficient evidence (very low)
Unchanged; no new relevant evidence.
In plain language
A third-party website has pages on Tayebat and diabetes, thyroid, PCOS, kidney disease and arthritis. These pages do not promise cures and repeatedly tell readers not to change medicines without their doctor. There is no study testing the system for these diseases. This cautious tone differs from many statements in Dr. Diaa's videos.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (0)
No studies in this group.
Studies with mixed or unclear results (1)
-
US diabetes guideline on food and lifestyle
American Diabetes Association Professional Practice Committee. Diabetes Care 2026 · PMID 41358898 · DOI 10.2337/dc26-S005Guideline / position statementindependent cross-checkfull text checked★ key studyThere is no single diet for diabetes; meals should be individualised with a dietitian, and medicines may need adjustment when the diet changes.
Supports supervision and limiting SSB/UPF; recommends foods the system forbids (legumes, vegetables, low-fat dairy).
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Give lifestyle and nutrition recommendations for diabetes
- How was the study done?
Evidence-graded guideline
- How many people, animals or samples were studied?
People with prediabetes or diabetes
- What was actually found?
Individualised plans; emphasise vegetables, legumes, whole grains; limit sugary drinks and ultra-processed foods
- How large was the observed effect?
Grade B recommendations
- What do the results mean in everyday life?
Changing your diet with diabetes is good but should be planned with your care team, especially if you take insulin.
- What are the study's limitations?
US guideline; not specific to Egypt
- What does it say about Elawady's specific claim?
Supports the caution on the third-party pages but not the exclusion of legumes, vegetables and dairy
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Whether the Tayebat system helps any disease
No study in this group is marked as key.
Regional context
Germany / EU
European diabetes care also individualises nutrition therapy (EASD/ADA consensus, not audited here). No European guideline recommends the Tayebat system.
Egypt
The pages are written for Arabic-speaking, largely Egyptian readers; no Egyptian data on outcomes of the system were found.
What applies in my country?
General scientific assessment
Unclear / insufficient evidence The third-party disease pages are cautious and make no cure claims; benefit is unproven.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee. Diabetes Care 2026 · PMID 41358898 · DOI 10.2337/dc26-S005